MDS Inc. Issues Annual Filings
29 Januar 2008 - 7:32PM
PR Newswire (US)
All Financial Statements for 2007 Now Available in US GAAP TORONTO,
Jan. 29 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a
leading provider of products and services to the global life
sciences markets, today announced that it has issued its annual
filings for the first time under US GAAP. These filings include the
Annual Report, Annual Information Form, Management Proxy Circular,
40-F, and the Canadian Supplement to the annual MD&A. To assist
investors with understanding the impact of the conversion from
Canadian to US GAAP, both an "MDS US GAAP Primer", which provides
an overview of the relevant differences between US and Canadian
GAAP affecting MDS, and reconciliation tables for MDS and its
business units are being made available on the MDS website. MDS
also published its interactive annual report today available at
http://www.mdsinc.com/. About MDS Inc. MDS Inc. is a global life
sciences company that provides market-leading products and services
that our customers need for the development of drugs and the
diagnosis and treatment of disease. We are a leading global
provider of pharmaceutical contract research, medical isotopes for
molecular imaging, radiotherapeutics, and analytical instruments.
MDS has more than 5,500 highly skilled people in 29 countries. Find
out more at http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24
hours a day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Senior
Vice-President, Investor Relations and External Communications, MDS
Inc., (416) 675-6777 X 34721,
Copyright